Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Thi Cuc Dinh"'
Autor:
Van‐Anh Nguyen Hoang, Sao Trung Nguyen, Trieu Vu Nguyen, Thanh Huyen Pham, Phuoc Loc Doan, Ngoc Thanh Nguyen Thi, Minh Long Nguyen, Thi Cuc Dinh, Dinh Hoang Pham, Ngoc Mai Nguyen, Duy Sinh Nguyen, Du Quyen Nguyen, Y‐Thanh Lu, Thanh Thuy Thi Do, Dinh Kiet Truong, Minh‐Duy Phan, Hoai‐Nghia Nguyen, Hoa Giang, Lan N. Tu
Publikováno v:
Molecular Oncology, Vol 17, Iss 4, Pp 598-610 (2023)
Breast cancer is the leading cause of cancer death in Vietnamese women, but its mutational landscape and actionable alterations for targeted therapies remain unknown. After treatment, a sensitive biomarker to complement conventional imaging to monito
Externí odkaz:
https://doaj.org/article/cb65bfefe411467fa96cfb5e19731f46
Autor:
Huu Thinh Nguyen, Trieu Vu Nguyen, Van-Anh Nguyen Hoang, Duc Huy Tran, Ngoc An Le Trinh, Minh Triet Le, Tuan-Anh Nguyen Tran, Thanh Huyen Pham, Thi Cuc Dinh, Tien Sy Nguyen, Ky Cuong Nguyen The, Hoa Mai, Minh Tuan Chu, Dinh Hoang Pham, Xuan Chi Nguyen, Thien My Ngo Ha, Duy Sinh Nguyen, Du Quyen Nguyen, Y-Thanh Lu, Thanh Thuy Do Thi, Dinh Kiet Truong, Quynh Tho Nguyen, Hoai-Nghia Nguyen, Hoa Giang, Lan N. Tu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundColorectal cancer (CRC) is the fifth most common cancer with rising prevalence in Vietnam. However, there is no data about the mutational landscape and actionable alterations in the Vietnamese patients. During post-operative surveillance, c
Externí odkaz:
https://doaj.org/article/65493b02fd974665ac67434d44181479
Autor:
Van‐Anh Nguyen Hoang, Sao Trung Nguyen, Trieu Vu Nguyen, Thanh Huyen Pham, Phuoc Loc Doan, Ngoc Thanh Nguyen Thi, Minh Long Nguyen, Thi Cuc Dinh, Dinh Hoang Pham, Ngoc Mai Nguyen, Duy Sinh Nguyen, Du Quyen Nguyen, Y‐Thanh Lu, Thanh Thuy Thi Do, Dinh Kiet Truong, Minh‐Duy Phan, Hoai‐Nghia Nguyen, Hoa Giang, Lan N. Tu
Publikováno v:
Molecular oncology.
Breast cancer is the leading cause of cancer death in Vietnamese women, but its mutational landscape and actionable alterations for targeted therapies remain unknown. After treatment, a sensitive biomarker to complement conventional imaging to monito